Larvol Delta - A-Phase-2-Study-to-Assess-the-Safety-of-EI1071-and-the-Effects-of-EI1071-on-Neuroinflammation-in-Alzheimer39s-Disease-Patients

EI1071 - Elixiron Immunotherap

http://clinicaltrials.gov/ct2/show/NCT06745583

Dec 20, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next